$56.79 3.6%
Price vs. AI Score (Last 150 days)
Data gathered: December 11

Data Bits

Data Bits Value / Change Benchmark
Job Posts N/A N/A
Sentiment N/A N/A
Webpage traffic N/A N/A
Employee Rating N/A N/A
Google Trends N/A N/A
Linkedin Employees N/A N/A
Patents N/A N/A
4chan Mentions N/A N/A
Facebook Engagement N/A N/A
Facebook followers N/A N/A
Stocktwits Mentions N/A N/A
Stocktwits Subscribers N/A N/A
Twitter Followers N/A N/A
Youtube Subscribers N/A N/A
News Mentions N/A N/A
Reddit Mentions N/A N/A
Business outlook N/A N/A

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news


About Incyte

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States, Europe, Japan, and internationally.


Incyte
Price $56.79
Target Price Sign up
Market Cap $12.3B
Dividend Yield 0.0059
Industry Biotechnology

Similar companies

Company Price AI Score

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '23918M60M858M171M261M
Q2 '23954M68M886M204M265M
Q1 '23808M57M751M22M64M
Q4 '22929M59M870M28M121M
Q3 '22823M55M768M113M145M

Insider Transactions

SWAIN PAULA J filed to sell 77,530 shares at $65.1.
September 6 '23
Stein Steven H filed to sell 97,583 shares at $63.3.
August 3 '23
Pasquale Maria E filed to sell 68,524 shares at $84.1.
February 2 '23
Pasquale Maria E filed to sell 68,524 shares at $84.7.
February 1 '23
Dhanak Dashyant filed to sell 53,263 shares at $85.
January 30 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.